1
TITLE: Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
AUTHORS: Romero, A; Ramos, E; Lopez Munoz, F; De Los Rios, C; Egea, J; Gil Martin, E; Pita, R; Torrado, JJ; Serrano, DR; Juberias, A;
PUBLISHED: 2021, SOURCE: DISEASES, VOLUME: 9, ISSUE: 2
INDEXED IN: WOS
2
TITLE: Melatonin's efficacy in stroke patients; a matter of dose? A systematic review  Full Text
AUTHORS: Eva Ramos; Victor Farre Alins; Javier Egea; Francisco Lopez Munoz; Russel J Reiter; Alejandro Romero;
PUBLISHED: 2020, SOURCE: TOXICOLOGY AND APPLIED PHARMACOLOGY, VOLUME: 392
INDEXED IN: Scopus WOS
3
TITLE: Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?  Full Text
AUTHORS: Alejandro Romero; Eva Ramos; Francisco Lopez Munoz; Emilio Gil Martin; Germaine Escames; Russel J Reiter;
PUBLISHED: 2020, SOURCE: CELLULAR AND MOLECULAR NEUROBIOLOGY
INDEXED IN: Scopus WOS
4
TITLE: Melatonin Reduces NLRP3 Inflammasome Activation by Increasing alpha 7 nAChR-Mediated Autophagic Flux
AUTHORS: Victor Farre Alins; Paloma Narros Fernandez; Alejandra Palomino Antolin; Celine Decouty Perez; Ana Belen Lopez Rodriguez; Esther Parada; Alicia Munoz Montero; Vanessa Gomez Rangel; Francisco Lopez Manoz; Eva Ramos; Agueda Gonzalez Rodriguez; Luis Gandia; Alejandro Romero; Javier Egea;
PUBLISHED: 2020, SOURCE: ANTIOXIDANTS, VOLUME: 9, ISSUE: 12
INDEXED IN: Scopus WOS
5
TITLE: Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics  Full Text
AUTHORS: Ana Capote Moreno; Eva Ramos; Javier Egea; Francisco Lopez Munoz; Emilio Gil Martin; Alejandro Romero;
PUBLISHED: 2019, SOURCE: CANCERS, VOLUME: 11, ISSUE: 11
INDEXED IN: Scopus WOS